Edition:
United Kingdom

Biofrontera AG (BFRA.OQ)

BFRA.OQ on NASDAQ Stock Exchange Capital Market

12.95USD
12 Nov 2018
Change (% chg)

$-0.06 (-0.44%)
Prev Close
$13.01
Open
$12.95
Day's High
$12.95
Day's Low
$12.95
Volume
33
Avg. Vol
1,581
52-wk High
$17.87
52-wk Low
$11.25

Latest Key Developments (Source: Significant Developments)

Biofrontera Q3 Prelim Revenue Of EUR 5.6 Million
Wednesday, 10 Oct 2018 

Oct 10 (Reuters) - Biofrontera AG ::ANNOUNCES PRELIMINARY UNAUDITED SALES REVENUE FOR THE FIRST NINE MONTHS OF 2018 AND INCREASES REVENUE GUIDANCE.REVENUE OF BIOFRONTERA GROUP FOR PERIOD JANUARY TO SEPTEMBER 2018 WERE BETWEEN EUR 14.5 AND 14.7 MILLION.REVENUE IN Q3 WILL BE AROUND EUR 5.6 MILLION, COMPARED TO EUR 2.3 MILLION IN PREVIOUS YEAR.HAS RAISED ITS REVENUE GUIDANCE FOR CURRENT YEAR FROM EUR 16 - 20 MILLION TO EUR 19 - 22 MILLION.FORECAST FOR CONSOLIDATED NET INCOME IN 2018 REMAINS UNCHANGED.  Full Article

Deutsche Balaton Biotech: Alternative Consideration To Offer For Biofrontera Shares
Friday, 20 Jul 2018 

July 23 (Reuters) - Deutsche Balaton Biotech AG::SAID ON FRIDAY WITHIN THE OFFER FOR BIOFRONTERA <<>> SHARES, A WARRANT IS LISTED ON THE OPEN MARKET OF THE HANSEATIC STOCK EXCHANGE HAMBURG ON JULY 20, 2018 WITH 5.04 EUROS.THIS RESULTS IN A CONSIDERATION OF 1.00 EUROS AND A WARRANT (PRICE 5.04 EUROS) FOR A TOTAL OF 6.04 EUROS PER SHARE.  Full Article

Biofrontera Boards Recommend To Not Accept The Offer Of Deutsche Balaton Biotech AG
Monday, 11 Jun 2018 

June 11 (Reuters) - Biofrontera AG ::DGAP-NEWS: BIOFRONTERA AG: BIOFRONTERA PUBLISHED JOINT OPINION TO THE TENDER OFFER OF DEUTSCHE BALATON BIOTECH AG.BIOFRONTERA - MANAGEMENT BOARD AND SUPERVISORY BOARD IN THEIR JOINT OPINION AS WELL AS EMPLOYEES IN THEIR OWN STATEMENT RECOMMEND TO NOT ACCEPT OFFER.BIOFRONTERA - MANAGEMENT AND SUPERVISORY BOARDS ARE OF THE OPINION THAT THE CONSIDERATION OFFERED BY THE BIDDER IS INSUFFICIENT.  Full Article

Biofrontera Q1 Net Loss Stable At EUR 3.4 Mln
Wednesday, 30 May 2018 

May 30 (Reuters) - Biofrontera AG ::DGAP-NEWS: BIOFRONTERA AG: BIOFRONTERA REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS.REVENUES INCREASED 79% TO EUR4.7 MILLION FOR Q1 2018.GROSS PROFIT INCREASED 78% TO EUR4.0 MILLION FOR Q1 2018.RESEARCH AND DEVELOPMENT COSTS DECREASED 17% TO EUR0.9 MILLION IN Q1.Q1 NET LOSS WAS (EUR3.4 MILLION) COMPARED TO LOSS (EUR3.5 MILLION) YEAR AGO.  Full Article

Biofrontera Q1 Sales Revenues Between EUR 4.6-4.7 Mln
Thursday, 12 Apr 2018 

April 12 (Reuters) - Biofrontera AG ::ADHOC: BIOFRONTERA AG: BIOFRONTERA ANNOUNCES PRELIMINARY UNAUDITED SALES REVENUES FOR THE 1ST QUARTER 2018.REVENUES OF BIOFRONTERA GROUP FOR PERIOD JANUARY TO MARCH 2018 WERE BETWEEN 4.6 AND 4.7 MILLION EUROS.  Full Article

Deutsche Balaton: Voluntary Acquisition Offer For Shares Of Biofrontera
Friday, 16 Mar 2018 

March 19 (Reuters) - Deutsche Balaton AG ::SAID ON FRIDAY DEUTSCHE BALATON TO BID FOR BIOFRONTERA AG <<>>.TO SUBMIT A VOLUNTARY PURCHASE OFFER FOR UP TO 6.25 MLN SHARES OF BIOFRONTERA AG, WHICH CORRESPONDS TO ABOUT 14% OF THE CURRENTLY ISSUED SHARES OF BIOFRONTERA AG.DOES NOT PLAN TO BUY CONTROLLING STAKE.AIM OF THE ACQUISITION OFFER IS TO EXCEED THE BLOCKING THRESHOLD OF 25% BY THE JOINTLY ACTING SHAREHOLDERS DELPHI UNTERNEHMENSBERATUNGS AG AND DEUTSCHE BALATON AG.CONSIDERATION OFFERED FOR THE BIOFRONTERA SHARES EXPECTED TO BE COMPOSED OF A TRADABLE FINANCIAL INSTRUMENT AND NOMINAL CASH PAYMENT PER SHARE.  Full Article

Biofrontera: European Commission Approves Use Of Ameluz In Combination With Daylight Photodynamic Therapy
Monday, 5 Mar 2018 

March 5 (Reuters) - Biofrontera AG ::PTA-ADHOC: BIOFRONTERA AG: EUROPEAN COMMISSION APPROVES USE OF AMELUZ IN COMBINATION WITH DAYLIGHT PHOTODYNAMIC THERAPY.  Full Article

Biofrontera ADS Open At $13.00 In Debut, About 32 Pct Above IPO Price
Wednesday, 14 Feb 2018 

Feb 14 (Reuters) - :BIOFRONTERA ADS OPEN AT $13.00 IN DEBUT ON THE NASDAQ VERSUS IPO PRICE OF $9.88/ADS.  Full Article

Biofrontera Sets Price For New Shares At 4.00 Euros
Friday, 9 Feb 2018 

Feb 9 (Reuters) - Biofrontera AG ::BIOFRONTERA AG ANNOUNCES SUBSCRIPTION PRICE FOR NEW SHARES.‍SUBSCRIPTION PRICE FOR NEW SHARES WAS SET TODAY AT EUR 4.00​.  Full Article

Biofrontera AG Says Estimate That IPO Price Will Be Between $11 And $13 Per ADS
Wednesday, 31 Jan 2018 

Jan 31 (Reuters) - Biofrontera Ag ::BIOFRONTERA AG SAYS ESTIMATE THAT THE INITIAL PUBLIC OFFERING PRICE WILL BE BETWEEN $11.00 AND $13.00 PER ADS – SEC FILING‍​.BIOFRONTERA AG SAYS IT HAD PREVIOUSLY EXPECTED U.S. IPO PRICED BETWEEN $8.80 AND $10.80 PER ADS.  Full Article